Literature DB >> 31662525

Prognostic Significance of Clinicopathological and Molecular Features After Neoadjuvant Chemoradiotherapy in Rectal Cancer Patients.

Hee Jeong Cho1, Jin Ho Baek1, Dong Won Baek1, Byung Woog Kang1, Soo Jung Lee1, Hye Jin Kim2, Su Yeon Park2, Jun Seok Park2, Gyu Seog Choi2, Jong Gwang Kim3.   

Abstract

BACKGROUND/AIM: This study evaluated clinicopathological and molecular features and their prognostic impact on patients with locally advanced rectal cancer (LARC) who received preoperative chemoradiotherapy (CRT). PATIENTS AND METHODS: We retrospectively gathered data from 284 patients with LARC who underwent total mesorectal excision (TME) after CRT.
RESULTS: In the univariate analysis, lower yield pathologic T (ypT) category, yield pathologic N (ypN) category, yield pathologic TNM (ypTNM) stage, as well as the absence of lymphovascular invasion (LVI) and perineural invasion (PNI), were significantly associated with better disease-free survival (DFS) and overall survival (OS). Meanwhile, the expression of Ki-67, p53, and the mismatch repair (MMR) status showed no association with clinical outcomes. A multivariate survival analysis revealed that ypT category and LVI were independent prognostic factors of a worse DFS (HR=3.081, p-value=0.001; HR=2.818, p-value=0.030) and OS (HR=3.158, p-value=0.006; HR=3.837, p-value=0.014).
CONCLUSION: The ypT category and the presence of LVI were found to be prognostic factors for patients with LARC after CRT followed by TME. Copyright
© 2019, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Locally advanced rectal cancer; neoadjuvant chemoradiotherapy; prognostic factors

Mesh:

Year:  2019        PMID: 31662525      PMCID: PMC6899088          DOI: 10.21873/invivo.11691

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  30 in total

Review 1.  Adjuvant chemotherapy for rectal cancer: Is it needed?

Authors:  Kristijonas Milinis; Michael Thornton; Amir Montazeri; Paul S Rooney
Journal:  World J Clin Oncol       Date:  2015-12-10

2.  Preoperative versus postoperative chemoradiotherapy for rectal cancer.

Authors:  Rolf Sauer; Heinz Becker; Werner Hohenberger; Claus Rödel; Christian Wittekind; Rainer Fietkau; Peter Martus; Jörg Tschmelitsch; Eva Hager; Clemens F Hess; Johann-H Karstens; Torsten Liersch; Heinz Schmidberger; Rudolf Raab
Journal:  N Engl J Med       Date:  2004-10-21       Impact factor: 91.245

3.  Microsatellite Instability (MSI) as an Independent Predictor of Pathologic Complete Response (PCR) in Locally Advanced Rectal Cancer: A National Cancer Database (NCDB) Analysis.

Authors:  Shaakir Hasan; Paul Renz; Rodney E Wegner; Gene Finley; Moses Raj; Dulabh Monga; James McCormick; Alexander Kirichenko
Journal:  Ann Surg       Date:  2020-04       Impact factor: 12.969

4.  Prognostic factors for low rectal cancer patients undergoing intersphincteric resection after neoadjuvant chemoradiation.

Authors:  Soo Young Lee; Jeong Seon Jo; Hun Jin Kim; Chang Hyun Kim; Young Jin Kim; Hyeong Rok Kim
Journal:  J Surg Oncol       Date:  2015-05-14       Impact factor: 3.454

5.  Ki-67 and Survivin as Predictive Factors for Rectal Cancer Treated with Preoperative Chemoradiotherapy.

Authors:  Kozo Yoshikawa; Mitsuo Shimada; Jun Higashijima; Toshihiro Nakao; Masaaki Nishi; Chie Takasu; Hideya Kashihara; Syohei Eto; Yoshimi Bando
Journal:  Anticancer Res       Date:  2018-03       Impact factor: 2.480

Review 6.  Colorectal cancer due to deficiency in DNA mismatch repair function: a review.

Authors:  Andrew M Bellizzi; Wendy L Frankel
Journal:  Adv Anat Pathol       Date:  2009-11       Impact factor: 3.875

7.  Prognostic value of tumour regression grade in locally advanced rectal cancer: a systematic review and meta-analysis.

Authors:  J C Kong; G R Guerra; S K Warrier; A Craig Lynch; M Michael; S Y Ngan; W Phillips; G Ramsay; A G Heriot
Journal:  Colorectal Dis       Date:  2018-05-08       Impact factor: 3.788

8.  Prevalence and prognostic role of microsatellite instability in patients with rectal carcinoma.

Authors:  M Colombino; A Cossu; A Manca; M F Dedola; M Giordano; F Scintu; A Curci; A Avallone; G Comella; M Amoruso; A Margari; G M Bonomo; M Castriota; F Tanda; G Palmieri
Journal:  Ann Oncol       Date:  2002-09       Impact factor: 32.976

9.  Correlation between the Ki-67 proliferation index and response to radiation therapy in small cell lung cancer.

Authors:  Naoya Ishibashi; Toshiya Maebayashi; Takuya Aizawa; Masakuni Sakaguchi; Haruna Nishimaki; Shinobu Masuda
Journal:  Radiat Oncol       Date:  2017-01-13       Impact factor: 3.481

10.  Prognostic Significance of Tumor Regression in Locally Advanced Rectal Cancer after Preoperative Radiochemotherapy.

Authors:  Mirko Omejc; Maja Potisek
Journal:  Radiol Oncol       Date:  2017-12-07       Impact factor: 2.991

View more
  2 in total

1.  The Clinical Relevance of Frequent Germline Genetic Variants Detected by Targeted Sequencing in Patients With Rectal Adenocarcinoma (READ).

Authors:  Kevin Chih-Yang Huang; Shu-Fen Chiang; Tao-Wei Ke; William Tzu-Liang Chen; Tsung-Wei Chen; Kun-San Clifford Chao
Journal:  Cancer Genomics Proteomics       Date:  2020 May-Jun       Impact factor: 4.069

2.  Perineural invasion as a prognostic factor in patients with stage I-III rectal cancer - 5-year follow up.

Authors:  Milica Stojkovic Lalosevic; Tamara Milovanovic; Marjan Micev; Mirjana Stojkovic; Sanja Dragasevic; Milos Stulic; Ivan Rankovic; Vladimir Dugalic; Zoran Krivokapic; Aleksandra Pavlovic Markovic
Journal:  World J Gastrointest Oncol       Date:  2020-05-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.